Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway-tumour-stroma lung cancer model. [electronic resource]
Producer: 20160216Description: 111-9 p. digitalISSN:- 1873-4863
- Benzimidazoles -- pharmacology
- Cell Proliferation -- drug effects
- Cells, Cultured
- Drug Screening Assays, Antitumor -- methods
- Epithelial Cells -- cytology
- Fibroblasts -- cytology
- Humans
- Lung -- cytology
- Lung Neoplasms -- drug therapy
- Models, Biological
- Protein Kinase Inhibitors -- pharmacology
- Pyridones -- pharmacology
- Pyrimidinones -- pharmacology
- Tumor Microenvironment -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.